Work

Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-120244

Authors: Amy Wang, Howard Weiner, Richard A. Larson, Olatoyosi Odenike, Andrew S Artz, Michael R. Bishop, Lucy Godley, Michael Thirman, Satyajit Kosuri, Jane Churpek, Emily K Curran, Kristen Pettit, Wendy Stock, Hongtao Liu

Institutions: University of Chicago, University of Chicago Medical Center, University of Michigan

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2904547506

Cites:

Cited by:

Related to: 10